RUNX1T1 and colorectal carcinoma: When it comes to CRC, however, RUNX1T1 is proven to be a tumor-suppressive gene, the re-expression of which causes a significant decrease in CRC cell growth and proliferation as well as increased sensitivity to 5-flurouracil [54].